Viyash Scientific Limited VIYASH
NSE · India · Health Technology
INR 231.75-4.05 (-1.72%)
Market closed· · INR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · INR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Strong US growth and a strengthened balance sheet position the company for a record Q2 in API and future expansion.
Viyash Scientific Ltd (BOM:512529) reports its strongest quarter yet, with significant EBITDA growth and strategic plans for future expansion despite facing some operational challenges.
Viyash Scientific Ltd (BOM:512529) reports robust financial performance with a focus on companion animal business and CDMO opportunities, despite facing merger-related costs and market competition.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.